Osteoarthritis
RecruitingEfficacy and Safety of LTG-321 Compared with Placebo in Patients with Osteoarthritis of the Knee
- Disease:Osteoarthritis
- Substances:–
Denmark- Participants:18–64 years · 65+ years
- Sponsor:Latigo Biotherapeutics Inc.
Rare diseases
Investigational molecules
Locations
1290 Rancho Conejo Boulevard Suite 102, 91320-1408, United States
Latigo Biotherapeutics Inc. is engaged in clinical research focused on osteoarthritis of the knee, with attention to conditions that affect joint function, mobility, and chronic pain.
The sponsor’s clinical activity reflects interest in therapeutic options for degenerative joint disease and the management of symptoms associated with articular cartilage deterioration.
Latigo Biotherapeutics Inc. runs clinical trials in conditions such as Osteoarthritis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Denmark
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.